Brazil
Egypt
Europe
Hong Kong
Malaysia
Mexico
Morocco
Philippines
Saudi Arabia
South Africa
Taiwan
Thailand
Tunisia
Turkey
UAE
USA
Vietnam
Global HQ
Press Releases
Biocon Biologics Receives DCGI Approval for Emergency Use of CytoSorb® to Treat Critical COVID-19 Patients
- Wed, 27-May-2020
- Posted by: Biocon Biologics
No Comments
Biocon Biologics Receives EU GMP Certification for Multiple Biosimilars Manufacturing Facilities in Bengaluru; Expands its Manufacturing Capacity
- Tue, 19-May-2020
- Posted by: Biocon Biologics
Biocon Earnings Q4FY20 Revenue Up 6% at Rs 1,644 Cr; EBITDA Down 11% at Rs 382 Cr; Net Profit Down 42% at Rs 123 Cr
- Thu, 14-May-2020
- Posted by: Biocon Biologics
Biocon and Mylan Launch Fulphila®, Biosimilar Pegfilgrastim, in Canada
- Tue, 28-Apr-2020
- Posted by: Biocon Biologics
Kiran Mazumdar-Shaw Recognized among World’s Top 20 Inspirational Leaders in Biopharmaceuticals in The Medicine Maker ‘Power List 2020’
- Mon, 27-Apr-2020
- Posted by: Biocon Biologics
Biocon and Mylan Launch Fulphila®, Biosimilar Pegfilgrastim, in Australia
- Tue, 14-Apr-2020
- Posted by: Biocon Biologics
Biocon & Biocon Biologics Ensuring Manufacturing of Life-Saving Medicines for Patients, Partners and Customers
- Fri, 27-Mar-2020
- Posted by: Biocon Biologics
Biocon & Mylan Win Patent Litigation Asserted by Sanofi for Insulin Glargine Device Patent in U.S.
- Wed, 11-Mar-2020
- Posted by: Biocon Biologics
U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon’s Proposed Biosimilar Bevacizumab for Review
- Mon, 09-Mar-2020
- Posted by: Biocon Biologics
Kiran Mazumdar-Shaw Named EY Entrepreneur of the Year India 2019
- Thu, 20-Feb-2020
- Posted by: Biocon Biologics
